BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:19 PM
Sep 26, 2007
 |  BC Extra  |  Top Story

NPS, Nycomed in Gattex deal

NPSP granted Nycomed (Zurich, Switzerland) exclusive rights to develop and commercialize Gattex teduglutide to treat gastrointestinal disorders outside of North America. NPSP will receive $35 million up front and is...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >